1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide
C22H18FN3O4 — CID 172662132
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide
1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide (PubChem CID 172662132) has the molecular formula C22H18FN3O4 and a molecular weight of 407.40 g/mol. Its IUPAC name is 1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide.
Molecular Properties
| Compound Name | 1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide |
|---|---|
| PubChem CID | 172662132 |
| Molecular Formula | C22H18FN3O4 |
| Molecular Weight | 407.40 g/mol |
| Exact Mass | 407.13 |
| IUPAC Name | 1-(4-fluorophenyl)-4-methyl-N-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)-2-oxopyridine-3-carboxamide |
| SMILES | Cc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc2c(c1)N(C)C(=O)CO2 |
| InChI | InChI=1S/C22H18FN3O4/c1-13-9-10-26(16-6-3-14(23)4-7-16)22(29)20(13)21(28)24-15-5-8-18-17(11-15)25(2)19(27)12-30-18/h3-11H,12H2,1-2H3,(H,24,28) |
| InChIKey | NXLOBVBQHUAWDN-UHFFFAOYSA-N |
| XLogP | 2.89 |
| TPSA | 80.64 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 407.40 |
| LogP ≤ 5 | 2.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172662132 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.